Julius Clinical

When. Trials. Matter.

Our Therapeutic Areas

CNS diseases.  
Cardio metabolic.  
Infectious diseases.

Central Nervous System

CNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts. 

Read more

Cardio-metabolic

Julius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients. 

Read more

Infectious Diseases & Vaccines

Unrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.

Read more

Central Nervous System

CNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts. 

Read more

Cardio-metabolic

Julius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients. 

Read more

Infectious Diseases & Vaccines

Unrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.

Read more

Our track record

Discover our story

Our Unique Triangle

Our industry-leading combination of scientific leadership, site networks, and operational excellence forms the unique triangle that is the foundation of our success.

NAFLD: patient identification strategies

In this webinar, Prof. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely im...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.

Download

"*" indicates required fields

*

Request for proposal

"*" indicates required fields

*
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn